BRIEF published on 04/02/2025 at 16:23, 1 year 2 months ago Distribution of Capital and Voting Rights at LNA Santé as of March 31, 2025 Voting Rights Capital Distribution Crossing Thresholds LNA Health
REGULATED PRESS RELEASE published on 04/02/2025 at 16:18, 1 year 2 months ago LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/03/2025 Déclaration de Société Générale concernant la répartition du capital et des droits de vote au 31/03/2025. Informations réglementaires sur les actions en circulation Société Générale LNA Santé Droits De Vote AMF Répartition De Capital
BRIEF published on 03/26/2025 at 18:12, 1 year 2 months ago LNA Santé Reports 2024 Annual Results: Targets Achieved Amidst Challenges LNA Santé Financial Performance Operating Profit Healthcare Growth 2024 Results
BRIEF published on 03/26/2025 at 18:12, 1 year 2 months ago LNA Santé publie ses résultats annuels 2024 : des objectifs atteints malgré les difficultés LNA Santé Performance Financière Résultats 2024 Bénéfice D'exploitation Croissance Des Soins De Santé
REGULATED PRESS RELEASE published on 03/26/2025 at 18:07, 1 year 2 months ago LNA SANTE : 2024 Annual Results LNA Santé reports solid 2024 results with operating sales of €793.9m, organic growth of 6.7% and net profit of €29.7m. Continued growth and improved financial structure expected in 2025 LNA Santé Financial Structure Organic Growth 2024 Results 2025 Forecast
REGULATED PRESS RELEASE published on 03/26/2025 at 18:04, 1 year 2 months ago LNA SANTE : Résultats annuels 2024
BRIEF published on 03/05/2025 at 15:25, 1 year 3 months ago Répartition du capital et droits de vote chez LNA Santé au 28 février 2025 Capital LNA Santé Droits De Vote Franchissements De Seuil Auto-contrôle
BRIEF published on 03/05/2025 at 15:25, 1 year 3 months ago Distribution of capital and voting rights at LNA Santé as of February 28, 2025 Voting Rights Capital LNA Health Threshold Crossings Self-control
REGULATED PRESS RELEASE published on 03/05/2025 at 15:20, 1 year 3 months ago LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 28/02/2025 Société Générale déclare la répartition de capital et des droits de vote au 28/02/2025 selon l'article 223-16 de l'AMF. Informations indicatives Capital Société Générale Droits De Vote AMF Répartition
BRIEF published on 02/06/2025 at 18:05, 1 year 4 months ago LNA Santé Reports Robust 2024 Growth Amid Regulatory Challenges Financial Performance International Growth Regulatory Challenges 2025 Forecast Outpatient Care
Published on 06/26/2026 at 14:05, 6 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 11 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 1 hour 11 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 01:40, 12 hours 31 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/26/2026 at 14:00, 11 minutes ago Hong Kong celebrates surge of global enterprises driving investment and opportunities
Published on 06/26/2026 at 14:00, 11 minutes ago Bitcoin Group SE publishes 2025 Annual Report: Strategic realignment ensures future viability in the dynamic crypto market
Published on 06/26/2026 at 13:32, 39 minutes ago Porsche ranks number one in J.D. Power 2026 U.S. Initial Quality Study
Published on 06/26/2026 at 13:30, 40 minutes ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
Published on 06/26/2026 at 13:30, 41 minutes ago AlphaESS Unveils Expanded Energy Storage Ecosystem for Europe at Intersolar 2026
Published on 06/26/2026 at 07:00, 7 hours 11 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 7 hours 11 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 19 hours 26 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 19 hours 41 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
